Memantine in Patients With Chronic Glaucoma

Phase 3CompletedNCT00168350

Allergan1,179 enrolled

Overview

Randomized double-masked clinical trial of memantine in patients with glaucoma

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

1,179

Sex: ALLMin age: 18 YearsMax age: 82 Years

Medical Language ↔ Plain English

Inclusion Criteria: * glaucoma damage on examination of visual field and optic disc * good visual acuity (with glasses if needed)

Progression of glaucoma

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.